The finch generates 100% of revenue from subscriptions to its best-in-class biotech stock research. We leverage our unique data advantage to model the fair valuation of biotech stocks, then show members how much they'd need to rise or fall in real time.
Help keep the platform -- including the Solt DB Biotech Company Database -- 100% free, open, and independent.
Support Solt DB's efforts to build an open and distributed bio-based future.
-cropped.svg)
.svg){kind=small}
.svg)
%20(squoosh).jpg)
